481 related articles for article (PubMed ID: 16050788)
1. American Society of Clinical Oncology 41st annual meeting.
Dillman RO
Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
[TBL] [Abstract][Full Text] [Related]
2. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
Tam VC; Hotte SJ
J Clin Oncol; 2008 May; 26(13):2205-11. PubMed ID: 18445846
[TBL] [Abstract][Full Text] [Related]
3. A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).
Rabasseda X; Gómez-Zaera M
Drugs Today (Barc); 2011 Sep; 47(9):693-737. PubMed ID: 21971543
[TBL] [Abstract][Full Text] [Related]
4. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Morgensztern D; Pennell NA; Subramanian J; Govindan R
Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology (ASCO) - 55th Annual Meeting (May 31-June 4, 2019 - Chicago, Illinois, USA).
Kibble A; Kuenneman K; de Las Heras Prat P
Drugs Today (Barc); 2019 Jun; 55(6):407-415. PubMed ID: 31250844
[TBL] [Abstract][Full Text] [Related]
6. [ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].
Höhler T; Heike M; Lutz MP; Graeven U; Seufferlein T;
Z Gastroenterol; 2005 Nov; 43(11):1253-9. PubMed ID: 16267711
[TBL] [Abstract][Full Text] [Related]
7. American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma.
Glavey SV; Ghobrial IM
Expert Rev Hematol; 2015 Jun; 8(3):273-5. PubMed ID: 25804827
[TBL] [Abstract][Full Text] [Related]
8. ASCO Plenary Sessions: impact, legacy, future.
Vandross A; Prasad V; Mailankody S
Semin Oncol; 2016 Jun; 43(3):321-6. PubMed ID: 27178681
[TBL] [Abstract][Full Text] [Related]
9. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
Montemurro F; Valabrega G; Garetto L; Aliberti S; Grignani G; Ortega C; Leone F; Ponzone R; Aglietta M
Expert Opin Pharmacother; 2005 Dec; 6(16):2907-21. PubMed ID: 16318441
[TBL] [Abstract][Full Text] [Related]
10. Neuro-oncology: a selected review of ASCO 2011 abstracts.
Chamberlain MC
Expert Rev Neurother; 2011 Oct; 11(10):1371-7. PubMed ID: 21955193
[TBL] [Abstract][Full Text] [Related]
11. Emerging new anticancer therapies in 2013.
Gomez-Roca C; Delord JP
Curr Opin Oncol; 2014 May; 26(3):357-62. PubMed ID: 24709976
[TBL] [Abstract][Full Text] [Related]
12. American society of clinical oncology--41st annual meeting. Immunology.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
[No Abstract] [Full Text] [Related]
13. 2015 American Society of Clinical Oncology annual meeting.
Cleghorn S
Lancet Respir Med; 2015 Jul; 3(7):516-7. PubMed ID: 26078097
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
15. Neuro-oncology: a selected review of ASCO 2012 abstracts.
Chamberlain MC
CNS Oncol; 2012 Nov; 1(2):127-30. PubMed ID: 25057862
[TBL] [Abstract][Full Text] [Related]
16. Trial results presented at ASCO's annual meeting highlight therapy de-escalation strategies: This year's American Society of Clinical Oncology annual meeting focused on the impact that targeted therapies can have on progression-free and disease-free survival.
Nierengarten MB
Cancer; 2023 Aug; 129(16):2438-2439. PubMed ID: 37475536
[No Abstract] [Full Text] [Related]
17. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
Shah S; Yager N
IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
[No Abstract] [Full Text] [Related]
18. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
20. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
